UK markets closed

Viridian Therapeutics, Inc. (0K1R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
13.80-0.15 (-1.08%)
At close: 05:04PM BST

Insider roster

Individual or entityMost-recent transactionDateShares owned as of transaction date

FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase

23 Sept 2021

1,505,200

LEVERONE JASON A. CPA
Chief Financial Officer

Conversion of Exercise of derivative security

13 Mar 2020

48,829

LOGOS GLOBAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security

Purchase

13 Nov 2020

550,000

LOGOS GLOBAL MASTER FUND, L.P.
Beneficial Owner of more than 10% of a Class of Security

Purchase

13 Nov 2020

550,000

MARSHALL WILLIAM STUART PH.D.
Chief Executive Officer

Stock Award(Grant)

21 Aug 2019

270,646

MEISNER LARA
Officer

Sale

16 Jun 2023

29,971

MYERS SCOTT DUNSETH
Chief Executive Officer

Purchase

12 Apr 2023

259,500

VIOLIN JONATHAN
Chief Executive Officer

Sale

02 Feb 2023

430,905

*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.